Volume 28, Number 6—June 2022
Research
Risk Prediction Score for Pediatric Patients with Suspected Ebola Virus Disease
Table 4
Demographic and clinical characteristics of patients, by EVD status at triage, in Democratic Republic of the Congo, December 2018–December 2019*
Characteristic† | Overall, no. (%), n = 1,336 | EVD positive, no (%), n = 84 (6%) | EVD negative, no. (%), n = 1,252 (94%) | OR (95% CI) | p value |
---|---|---|---|---|---|
Sex | |||||
M | 690 (52) | 32 (38) | 658 (53) | 0.56 (0.35–0.87) | 0.01 |
F |
646 (48) |
52 (62) |
594 (47) |
Referent |
|
Signs/symptoms | |||||
Fever | 818 (61) | 72 (86) | 746 (60) | 4.07 (2.27–7.96) | <0.001 |
Headache | 700 (52) | 47 (56) | 653 (52) | 1.17 (0.75–1.83) | 0.50 |
Breathlessness | 93 (7.0) | 13 (15) | 80 (6.4) | 2.68 (1.37–4.90) | 0.002 |
Bone/muscle pain | 116 (8.7) | 16 (19) | 100 (8.0) | 2.71 (1.47–4.74) | <0.001 |
Asthenia | 960 (72) | 62 (74) | 898 (72) | 1.11 (0.68–1.87) | 0.68 |
Abdominal pain | 458 (34) | 34 (40) | 424 (34) | 1.33 (0.84–2.08) | 0.22 |
Hiccups | 16 (1.2) | 1 (1.2) | 15 (1.2) | 0.99 (0.05–4.99) | >0.99 |
Any bleeding | 99 (7.4) | 21 (25) | 78 (6.2) | 5.02 (2.86–8.54) | <0.001 |
GI symptoms |
1,026 (77) |
84 (100) |
942 (75) |
55.7 (3.44–900) |
0.005 |
Ebola contact | |||||
Yes | 191 (14) | 54 (64) | 137 (11) | 5.40 (3.03–10.1) | <0.001 |
No known | 910 (68) | 14 (17) | 896 (71) | 0.21 (0.10–0.45) | |
No | 235 (18) | 16 (19) | 219 (17) | Referent |
*Age, y, mean (interquartile range): overall, 7 (2–11); EVD positive, 5 (1.4–13); EVD negative, 6 (2.5–11); OR 1.00 (95% CI 0.96–1.04); p = 0.96. EVD, Ebola virus disease; GI, gastrointestinal; OR, odds ratio. †Malaria was not reported for this cohort because rapid diagnostic tests for malaria were not conducted for all patients at the EVD treatment centers.
1These authors contributed equally to this article.
2These authors contributed equally to this article.
3Current affiliation: Pediatric Infectious Diseases & Immunology, Connecticut Children’s Medical Center, Hartford, Connecticut, USA.